A Phase II Trial of Tumour Infiltrating Lymphocyte Adoptive Cell Therapy in Patients With Immune Checkpoint Inhibitor Resistant Unresectable or Metastatic Melanoma

NCT07651618 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER_GOV

Sponsor class

Conditions

Melanoma (Skin Cancer)
Melanoma Metastatic

Interventions

BIOLOGICAL: Tumour Infiltrating Lymphocytes Adoptive Cell Therapy
DRUG: Cyclophosphamide + Fludarabine Lymphodepletive Conditioning
DRUG: Aldesleukin

Sponsor

East Metropolitan Health Service, Australia

Collaborators

[object Object]